Remove Artificial Intelligence Remove Business Transformation Remove Innovation Remove Pharmaceuticals
article thumbnail

Cardinal Health CIO Michelle Greene on simplifying transformation

CIO

Recently, I had the pleasure of speaking with Michelle Greene, who was promoted from SVP of EIT of Cardinal Health’s pharmaceutical segment to CIO last August. Central to that effort is structuring her IT organization to better partner with the business. Martha Heller: How do you define business transformation at Cardinal Health?

Analytics 299
article thumbnail

Cardinal Health CIO Michelle Greene on simplifying transformation

CIO

Recently, I had the pleasure of speaking with Michelle Greene, who was promoted from SVP of EIT of Cardinal Health’s pharmaceutical segment to CIO last August. Central to that effort is structuring her IT organization to better partner with the business. Martha Heller: How do you define business transformation at Cardinal Health?

Analytics 246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

IoT, AI, Blockchain: what does the future hold for mobile Healthcare

Apiumhub

Thanks to Artificial Intelligence, Blockchain, and IoT, people have to make fewer visits to the doctor and can stay inter-connected through a computer or mobile phones only. 2- Artificial Intelligence. Another wave of the future in healthcare is artificial intelligence. Top business blogs to read.

article thumbnail

And the winners are…. Congratulations to the Sixth Annual Data Impact Awards winners

Cloudera

These awards recognize organizations that transform complex data into actionable insights and illustrate impact to technology, science, health, lifestyle, and community across a wide variety of industries. Business Transformation: United Overseas Bank Group – UOB. Technical Impact. Enterprise Machine Learning: .

article thumbnail

Can data drive more successful R&D in life sciences?

Capgemini

Newly qualified data scientists who haven’t worked in R&D-heavy organizations, including life sciences and healthcare, can struggle to understand the pharmaceutical science and drug approval process, how best to represent and interpret it accurately with their tools, or where to focus their efforts. Experience and insight for the future.

Data 98